Evidence map›Paper›PMID 32564236›Full record

Trial reportTechniques in coloproctology2020

Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.

S J Moug, S J E Barry, S Maguire, N Johns, D Dolan, R J C Steele, C Buchan, G Mackay, A S Anderson, N Mutrie

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Techniques in coloproctology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Prehabilitation for muscle wasting in cancer: do definitions matter?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Review
  7. Review
  8. Total neoadjuvant therapy in early-onset rectal cancer: A multicentre prospective cohort study.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Prehabilitation in radiation therapy: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  17. Review
  18. Gastric Cancer with Sarcopenia: an Area Worth Focusing On.Current treatment options in oncology · 2023
    Review
  19. The effects of prehabilitation on body composition in patients undergoing multimodal therapy for esophageal cancer.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

S J MougDepartment of Surgery, Royal Alexandra Hospital, Corsebar Road, Paisley, PA2 9PN, UK. susanmoug@nhs.net.ORCID http://orcid.org/0000-0001-9969-9760
S J E BarryDepartment of Mathematics and Statistics, Strathclyde University, Glasgow, UK.
S MaguireUniversity of Glasgow, Glasgow, UK.
N JohnsWestern General Hospital, Crewe Road South, Edinburgh, UK.
D DolanUniversity of Glasgow, Glasgow, UK.
R J C SteeleNinewells Hospital and Medical School, Dundee, UK.
C BuchanDepartment of Surgery, Royal Alexandra Hospital, Paisley, UK.
G MackayDepartment of Surgery, Glasgow Royal Infirmary, Glasgow, UK.
A S AndersonDivision of Cancer Research, Ninewells Medical School, Dundee, UK.
N MutrieInstitute of Sport, Physical Education and Health Sciences, Moray House School of Education, Edinburgh, UK.
Ninewells Hospital · GBRoyal Alexandra Hospital · GBUniversity of Glasgow · GBGlasgow Royal Infirmary · GBUniversity of Strathclyde · GBWestern General Hospital · GB

Funding

Chief Scientist Office CZH/4/986Chief Scientist Office, Scottish Government Health and Social Care Directorate CZH/4/986
6 · The paper itself

Abstract

backgroundPatients with rectal cancer who present with sarcopenia (low muscle mass) are at significantly greater risk of postoperative complications and reduction in disease-free survival. We performed a subanalysis of a randomised controlled study [the REx trial; www.isrctn.com ; 62859294] to assess the potential of prehabilitation to modify muscle mass in patients having neoadjuvant chemoradiotherapy (NACRT).

methodsPatients scheduled for NACRT, then potentially curative surgery (August 2014-March 2016) had baseline physical assessment and psoas muscle mass measurement (total psoas index using computed tomography-based measurements). Participants were randomised to either the intervention (13-17-week telephone-guided graduated walking programme) or control group (standard care). Follow-up testing was performed 1-2 weeks before surgery.

resultsThe 44 patients had a mean age of 66.8 years (SD 9.6) and were male (64%); white (98%); American Society of Anesthesiologists class 2 (66%); co-morbid (58%); overweight (72%) (body mass index ≥ 25 kg/m

conclusionsPrehabilitation improved muscle mass in patients with rectal cancer who had NACRT. These results need to be explored in a larger trial to determine if the poorer short- and long-term patient outcomes associated with low muscle mass can be minimised by prehabilitation.

Indexed as

Rectal NeoplasmsSarcopeniaAgedFemaleHumansMaleNeoadjuvant TherapyPostoperative ComplicationsPreoperative ExerciseMuscle wastingNeoadjuvant chemoradiotherapyNeoadjuvant therapyPrehabilitationPreoperative careRectal cancerRectal neoplasmsSarcopeniaWalking

Identifiers

PMID32564236
PMCPMC7429543
OpenAlexW3035787185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.